rs207460005
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
Variant has been reported in ClinVar as Likely pathogenic (★★★).
Frequency
Consequence
frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYTB | unassigned_transcript_4818 | c.41_44delTTAA | p.Ile14fs | frameshift_variant | Exon 1 of 1 | |||
ND6 | unassigned_transcript_4816 | c.-111_-108delAATT | upstream_gene_variant | |||||
TRNE | unassigned_transcript_4817 | c.-42_-39delAATT | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
Mitomap
ClinVar
Submissions by phenotype
Parkinsonism/MELAS overlap syndrome Pathogenic:1
- -
Mitochondrial disease Pathogenic:1
The m.14787_14790delTTAA (p.Ile14ThrfsTer27) variant in MT-CYB has been reported in one individual to date, in a man with features consistent with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and akinetic rigid syndrome. Clinical features included fine motor incoordination, concentration difficulty, fatigue, periods with regressive behavior, Wolff-Parkinson-White arrhythmia, mild left ventricular hypertrophy, seizures, and cortical blindness. He walked with a flexed body posture, reduced arm swing, mild shuffling gait, had resting tremor of the hands, and increased muscle tone. Brain MRI showed diffuse atrophy and lesions consistent with cerebral infarcts in the left and right parietooccipital region. Blood and cerebrospinal fluid lactate levels were elevated. Muscle biopsy electron microscopy showed aggregates of subsarcolemmal mitochondria. He had an isolated complex III deficiency in muscle (14% lowest normal value). The variant was present at 60% heteroplasmy in blood, 60% in hair, 60% in buccal, 60% in fibroblasts, and 95% muscle (PMID: 9894888). As this is the only case reported to date, PS4 could not be applied. The variant was absent in blood, buccal, and hair samples from his healthy mother (PM6_supporting). Computational predictors are not applicable for this variant type precluding consideration for PP3 or BP4. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). This variant results in a frame shift from codon 13 onward and is predicted to result in a nonsense stretch of amino acids terminating at an early stop at codon 50 (PVS1_strong). There are no cybrids, single fiber studies, or other functional assays reported on this variant. In summary, this variant meets criteria to be classified as likely pathogenic for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on December 11, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM6_supporting, PM2_supporting, PVS1_strong. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at